Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Lattice Biologics Ltd. (V:LBL)

Business Focus: Medical Devices & Implants

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for LBL within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Jul 09, 2021 14:02 ET
Lattice Biologics Ltd. Reports Second Quarter 2021 Results and Resumes Trading
Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces financial results for Q2 2021.
Read full article
Jun 07, 2021 07:57 ET
IIROC Trading Halt - LBL
VANCOUVER, BC, June 7, 2021 /CNW/ - The following issues have been halted by IIROC:
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
N/A
--
--
Price to Sales - TTM
1.95
1.95
3.46
Price to Book - most recent quarter
--
--
2.02
Price to Cash Flow per share - TTM
--
--
9.70
Price to Free Cash Flow per share - TTM
--
--
12.33
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Mar 15, 2024490
Feb 29, 2024490
Feb 15, 2024490
See Short Report

Business Summary

Sector:  Healthcare Industry:  Medical Equipment, Supplies & Distribution

Lattice Biologics Ltd. is engaged in the business of developing, manufacturing and marketing biologics products to domestic and international markets. The Company's products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company's stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

See business summary

 

Twitter

Search (past week) for $LBL.CA LBL.V

  • No tweets found